Citadel Advisors’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-59,281
| Closed | -$2.7K | – | 6775 |
|
|
2022
Q4 | $2.7K | Sell |
59,281
-58,683
| -50% | -$2.68K | ﹤0.01% | 5856 |
|
|
2022
Q3 | $8K | Sell |
117,964
-2,622
| -2% | -$178 | ﹤0.01% | 5668 |
|
|
2022
Q2 | $18K | Sell |
120,586
-173,015
| -59% | -$25.8K | ﹤0.01% | 5735 |
|
|
2022
Q1 | $88K | Sell |
293,601
-46,618
| -14% | -$14K | ﹤0.01% | 5708 |
|
|
2021
Q4 | $173K | Sell |
340,219
-20,916
| -6% | -$10.6K | ﹤0.01% | 5580 |
|
|
2021
Q3 | $198K | Buy |
361,135
+163,217
| +82% | +$89.5K | ﹤0.01% | 5431 |
|
|
2021
Q2 | $200K | Buy |
+197,918
| New | +$200K | ﹤0.01% | 5586 |
|